Acute & Chronic Post-mastectomy Pain: Can PECS Block Alter the Geography?
1 other identifier
interventional
40
1 country
1
Brief Summary
Post mastectomy pain management is of crucial importance for patients' rehabilitation and quality of life. PECS block is used for acute and chronic post mastectomy pain management. Surgical infiltration is also used in this field. Patients in our study are divided in two groups receiving PECS block or surgical infiltrationbefore incision. Multimodal analgesia is indispensable according to recent guidelines for enhanced postoperative recovery. Pain scores will be assessed during the first 24h postoperatively and at 3 months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2020
CompletedFirst Submitted
Initial submission to the registry
June 21, 2020
CompletedFirst Posted
Study publicly available on registry
June 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 23, 2020
June 1, 2020
3.6 years
June 21, 2020
June 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intensity of acute postoperative pain
intensity of acute postoperative pain, numeric rating scale 0-10
24 hours
Secondary Outcomes (3)
intensity of chronic pain
3 months
Prevalence of chronic neuropathic pain
3 months
Prevalence of chronic neuropathic pain
3 months
Study Arms (2)
PECS block
ACTIVE COMPARATORlocal infiltration
ACTIVE COMPARATORInterventions
PECS block is performed at the side of surgery (II) before incision with ropivacaine 0,375%.(30 ml). General anesthesia is induced and maintained with midazolam, fentanyl, propofol and rocuronium. Pain is assessed postoperatively according to protocol (24 hours and after 3 months).
local infiltration of the surgical wound before incision with πwith ropivacaine 0,375%.(30 ml). General anesthesia is induced and maintained with midazolam, fentanyl, propofol and rocuronium. Pain is assessed postoperatively according to protocol (24 hours and after 3 months).
Eligibility Criteria
You may qualify if:
- over 18 years of age
- ASA physical status I-III
- elective partial mastectomy
You may not qualify if:
- refusal of patient participation or inability to participate to the study
- known allergic reaction to drugs included in the study design
- contraindiations of performance of peripheral regional anesthesia
- diabetes melitus or known neurological disorder
- chronic pain disorders under therapy with opioids or other analgesic drugs for chronic pain
- all male patients
- all patients not speaking the Greek language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Attikon Hospitallead
Study Sites (1)
2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str.
Athens, 12462, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- PATIENT OUTCOME ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anaesthesiology
Study Record Dates
First Submitted
June 21, 2020
First Posted
June 23, 2020
Study Start
May 20, 2020
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
June 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share